Personalization of Opioid Prescription Following Orthognathic Surgery

NCT05708521 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

201

Enrollment

OTHER

Sponsor class

Conditions

Pain, Postoperative
Orthognathic Surgery
Opioid Use
Patient Satisfaction
Opioid Use Disorder

Interventions

DRUG: Personalization of dose and frequency and instituting a tapering protocol of hydromorphone post-orthognathic surgery
DRUG: Standardized dose and frequency of hydromorphone with no tapering post-orthognathic surgery

Sponsor

Nova Scotia Health Authority